A Study on the Use of Canakinumab Among Familial Mediterranean Fever and Still's Disease Patients

Clinical trial NCT07517250 · RECRUITING

Trial details

NCT number: NCT07517250
Sponsor: Novartis Pharmaceuticals
Status: RECRUITING
Study type: OBSERVATIONAL

Familial Mediterranean Fever Still Disease Systemic Juvenile Idiopathic Arthritis Adult-Onset Still Disease

Start date: 2026-03-15
Primary completion: 2026-12-03
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.